These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Controversies in the Therapy of Brain Metastases: Shifting Paradigms in an Era of Effective Systemic Therapy and Longer-Term Survivorship. Shen CJ; Lim M; Kleinberg LR Curr Treat Options Oncol; 2016 Sep; 17(9):46. PubMed ID: 27447703 [TBL] [Abstract][Full Text] [Related]
45. Stereotactic radiosurgery for multiple brain metastases. Lam TC; Sahgal A; Chang EL; Lo SS Expert Rev Anticancer Ther; 2014 Oct; 14(10):1153-72. PubMed ID: 25034143 [TBL] [Abstract][Full Text] [Related]
46. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710 [TBL] [Abstract][Full Text] [Related]
48. Whole-brain radiotherapy and stereotactic radiosurgery in brain metastases: what is the evidence? Mehta MP; Ahluwalia MS Am Soc Clin Oncol Educ Book; 2015; ():e99-104. PubMed ID: 25993245 [TBL] [Abstract][Full Text] [Related]
53. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors. Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933 [TBL] [Abstract][Full Text] [Related]
54. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Lo SS; Chang EL; Suh JH Expert Rev Neurother; 2005 Jul; 5(4):487-95. PubMed ID: 16026232 [TBL] [Abstract][Full Text] [Related]
56. Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease. Chen H; Louie AV; Higginson DS; Palma DA; Colaco R; Sahgal A Clin Oncol (R Coll Radiol); 2020 Nov; 32(11):713-727. PubMed ID: 32718762 [TBL] [Abstract][Full Text] [Related]
57. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma. Tsao MN; Mehta MP; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):47-55. PubMed ID: 16111571 [TBL] [Abstract][Full Text] [Related]
58. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Sahgal A; Aoyama H; Kocher M; Neupane B; Collette S; Tago M; Shaw P; Beyene J; Chang EL Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):710-7. PubMed ID: 25752382 [TBL] [Abstract][Full Text] [Related]
59. Stereotactic radiosurgery alone for multiple brain metastases? A review of clinical and technical issues. Sahgal A; Ruschin M; Ma L; Verbakel W; Larson D; Brown PD Neuro Oncol; 2017 Apr; 19(suppl_2):ii2-ii15. PubMed ID: 28380635 [TBL] [Abstract][Full Text] [Related]
60. A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Tsao M; Xu W; Sahgal A Cancer; 2012 May; 118(9):2486-93. PubMed ID: 21887683 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]